NEWS
Our Latest News
ARCHIMED earns 5x its investment, selling a majority of Ad-Tech to Tokyo-listed Nihon Kohden
ARCHIMED earns 5x its investment, selling a majority of Ad-Tech to Tokyo-listed Nihon Kohden
As part of the transaction, Nihon Kohden, one of the largest developers and distributors of medical electronic equipment in the world, is entering a joint-venture with ARCHIMED to pursue Ad-Tech’s growth in North America, Europe, and Asia.
ARCHIMED acquires Irrimax, market leader in anti-microbial wound irrigation solutions
August
28,
2024
ARCHIMED concludes successfully its £203 million take-private bid for drug development software leader Instem
November
27,
2023
ARCHIMED creates a leading specialized dermatological-focused CRO via the simultaneous purchase & merger of Symbio and Proinnovera
November
17,
2023
ARCHIMED top-ranked buyout fund MED I earns 4.5x on the sale of Vita
October
27,
2023
368